RPS Pharma Scene #3 - the role of Industrial Pharmacy
With Nathalie Moll and Sunayana Shah
This episode, RPS Chief Scientist Gino Martini chats with Nathalie Moll and Sunayana Shah about the role of industrial pharmacy, and their experiences as pharmacists during the pandemic.
Nathalie has been Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since 2017.
And Sunayana is an expert in regulatory, medical, and pharmacovigilance policy development.
Join them to discover how industrial pharmacy is changing and contributing to healthcare around the world.
Nathalie Moll joined the European Federation of Pharmaceutical Industries and Associations (EFPIA) as Director General in April 2017.
EFPIA represents the pharmaceutical industry operating in Europe. Together with its direct membership 40 leading pharmaceutical companies, 33 national associations representing over 1,900 companies and in collaboration with health and research players, EFPIA's mission is to create an environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.
Prior to joining EFPIA, between 2010 and 2017 Nathalie was the Secretary General of EuropaBio ranked as the most effective European Trade Association in Brussels in 2013. She spent over 20 years working for the biotech industry at EU and national level in associations and corporate positions and held the position of Chair and Vice Chair of the International Council of Biotech Associations (ICBA).
In 2013, Nathalie won the Technovisionaries Women Innovation Award organised by Women & Technologies® while in 2009, Nathalie and the Green Biotech Team of EuropaBio were presented with the Leadership and Excellence in Advancing Ag-Biotech and Food Issues Award. Nathalie was also named one of the 15 leading women in biotech in Europe in 2017.
Nathalie holds an Honours Degree in Biochemistry and Biotechnology from St Andrews University, Scotland.
Sunayana Shah is an expert in regulatory, medical, and pharmacovigilance policy development as well as technical, scientific, and regulatory intelligence at global level including working with WHO, European and UK organisations.
She has collaborated with government, NGO and clinical leaders at national, regional and international levels within the health sector.
Sunayana has extensive experience in complex stakeholder management, policy analysis and development and communication, particularly in complex technical areas to improve understanding.
Sunayana worked at the Association of the British Pharmaceutical Industry (ABPI), London, where as Head of Regulatory and Safety Policy she advised the pharmaceutical industry and worked with senior UK and EU government officials on international regulatory policy issues, including the impact of Brexit.
Previously, she led the scientific and medical affairs function at the Proprietary Association of Great Britain (PAGB) where she developed and implemented national and pan European and global OTC reclassification policy, regulatory expertise, and led the Professional Learning training programmes. She was also Senior Staff editor of the British National Formulary at the Royal Pharmaceutical Society, London and is an expert across many therapeutic areas.
Sunayana has also worked extensively in Community Pharmacy. Sunayana holds an honours degree from the School of Pharmacy, University of London, with Post Graduate Diplomas in Evidence based Pharmacotherapy (Aston University) and Community Pharmacy (University of Keele).
She is a GPhC registered pharmacist and RPS Ambassador, and was awarded a Fellowship of the Royal Pharmaceutical Society in 2018.